FDA expands recall of blood pressure drug valsartan due to cancer concern

FDA expands recall of blood pressure drug valsartan due to cancer concern  whnt.com Somaliland Health Authorities Recall Valsartan, other Risk-Drugs From Markets  MENAFN.COM India's Hetero pulls heart drug from US amid cancer risk probes  ZAWYAFull coverage

(CLICK HERE TO READ AND SEE MORE)